Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 81 | ECE2022 | Next issue

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

The 24th European Congress of Endocrinology (ECE) and the Italian Society of Endocrinology look forward to welcoming you to Milan. ECE 2022 returns for a four day, six parallel session festival of endocrine science. You can join us In person in Milan, Italy OR Live @Home online!

Debate Sessions

PRRT or targeted molecular therapies as preferred line of treatment

Table of contents

Next section
Pituitary adenoma or pituitary tumor?

ea0081d1.1 | PRRT or targeted molecular therapies as preferred line of treatment | ECE2022

For: PRRT or targeted molecular therapies as preferred line of treatment

de Herder Wouter W

Purpose: Bronchopulmonary (BP) and gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are slow-growing tumors, which frequently express somatostatin receptors on their cell membranes. These receptors are targets for therapy with 177Lutetium-labeled somatostatin analogues.Experimental Design: Patients receive four treatments of 177Lu-DOTATATE at a dose of 7.4 GBq every 8 weeksResults: An objective resp...

0 shares

ea0081d1.2 | PRRT or targeted molecular therapies as preferred line of treatment | ECE2022

Abstract unavailable...

0 shares

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more